I will have a crack. back of envelope stuff so comment but dont...

I will have a crack.
back of envelope stuff so comment but dont be tools! Constructively contribute to my back if envelope both positive and negative

FY22 (f) of 9mill revenue. 5 year cagr of 42%. Lets scale that back to 30% and give FY 23 as 12mill plus rhinoswab btnx MINIMUM deal. Min deal of 11m units at circa 80c is 9mill. Add that to 12mill = 21mill revenue. At these revenue number costs will be circa 20mill i reckon.
now upside is if they deliver in excess of the 11m units to btnx and convert pipeline to contracts to revenue. I reckon 50% of any future rhinoswab and other revenue should drop to bottom line so could be significantly profitable in fy24 if a chunk of pipeline gets converted.